? ? Sickle cell anemia is a disease of the red blood cell that results in anemia and repeated bouts of decreased blood flow to vital organs resulting in progressive damage to many organs including the kidneys, lungs, and brain. The transfusion of red blood cells can ameliorate many of these complications, but can be associated with both acute and chronic complications. The objective of the proposed Best Practices in Transfusion Medicine for Patients with Sickle Cell Disease (SCD) is to develop explicit clinical pathways for the use of red blood cells in SCD patients. Use of these pathways will improve the care for these patients. (End of Abstract) ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Conference (R13)
Project #
1R13HL090075-01
Application #
7330268
Study Section
Special Emphasis Panel (ZHL1-CSR-L (M2))
Program Officer
Luksenburg, Harvey
Project Start
2007-07-15
Project End
2010-06-30
Budget Start
2007-07-15
Budget End
2010-06-30
Support Year
1
Fiscal Year
2007
Total Cost
$20,000
Indirect Cost
Name
University of California Davis
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618